Earnings History Data for Baudax Bio (BXRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Baudax Bio
Baudax Bio Inc. is a pharmaceutical company. It is focused on advancing non-opioid analgesics and other products for the hospital and other acute care settings. The Company's lead product candidate is a proprietary intravenous form of meloxicam, a non-opioid, long-acting preferential COX-2 inhibitor. Baudax Bio Inc. is based in Malvern, Pennsylvania.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
20-11-2023 | AH | BXRX | Baudax Bio | 1.00 | -0.29 | -0.53 | 0.00 | 0.0718 | -0.01 (-7.57%) |
0.0 | 0.0 (0.00%) |
0.07 - 7.64 | 335,830 | 390,000 | 0 | |||
|
||||||||||||||||||
16-08-2023 | PM | BXRX | Baudax Bio | 4.00 | -1.49 | -2.04 | 0.00 | Baudax Bio GAAP EPS of -$1.49 beats by $0.55 [8/16/2023 1:49 PM] |
0.5572 | -0.02 (-3.11%) |
0.59 | 0.01 (2.57%) |
0.50 - 37.72 | 76,600 | 80,000 | 2,849 | ||
12-05-2023 | PM | BXRX | Baudax Bio | 2.00 | -3.19 | 5.75 | 0.00 | Baudax Bio GAAP EPS of -$3.91 [5/12/2023 11:33 AM] |
0.67 | -0.01 (-1.47%) |
0.66 | -0.02 (-2.93%) |
0.65 - 50.00 | 196,653 | 450,000 | 20,057 | ||
08-11-2022 | AH | After the close (Nov 8) |
BXRX | Baudax Bio | 4.00 | -2.47 | -0.53 | 0.00 | Baudax Bio GAAP EPS of -$2.47, revenue of $0.24M [11/8/2022 5:51 PM] |
0.1333 | -0.04 (-24.82%) |
0.17 | 0.0 (-2.14%) |
0.13 - 19.25 | 1,587,150 | 480,000 | 79,994 | |
16-03-2022 | PM | BXRX | Baudax Bio, Inc. | 7.77 | 10.04 | 0.00 | 0.00 | Baudax Bio GAAP EPS of $10.03, revenue of $0.4M [3/16/2022 8:55 AM] |
1.76 | 0.14 (8.64%) |
1.70 | 0.08 (4.93%) |
1.49 - 55.30 | 383,736 | 445,671 | 8,046 | ||
04-11-2021 | PM | 7:00 AM ET (Nov 4) |
BXRX | Baudax Bio, Inc. | 45.48 | -0.20 | -0.16 | -0.72 | Baudax Bio EPS misses by $0.05, misses on revenue [11/4/2021 7:07 AM] |
0.5289 | -0.04 (-6.22%) |
0.54 | -0.03 (-4.61%) |
0.50 - 2.12 | 1,814,260 | 1,570,000 | 146,898 | |
05-08-2021 | PM | 7:00 AM ET (Aug 5) |
BXRX | Baudax Bio, Inc. | 51.57 | -0.21 | -0.22 | -0.74 | Baudax Bio EPS misses by $0.01, misses on revenue [8/5/2021 7:08 AM] |
0.5589 | -0.04 (-7.10%) |
0.60 | 0.0 (-0.28%) |
0.54 - 3.94 | 3,806,208 | 680,000 | 77,748 | |
05-05-2021 | PM | 7:05 AM ET (May 5) |
BXRX | Baudax Bio, Inc. | 79.26 | -0.19 | -0.19 | -0.83 | Baudax Bio EPS misses by $0.08, misses on revenue [5/5/2021 7:12 AM] |
0.9080 | -0.14 (-13.52%) |
1.04 | -0.01 (-0.95%) |
0.90 - 4.95 | 6,048,369 | 1,650,000 | 60,631 | |
16-02-2021 | PM | 7:05 AM ET (Feb 16) |
BXRX | Baudax Bio, Inc. | 90.77 | N/A | -0.60 | 0.00 | Baudax Bio EPS misses by $3.33, misses on revenue [2/16/2021 7:06 AM] |
1.77 | -0.14 (-7.39%) |
1.89 | -0.02 (-1.05%) |
0.97 - 10.14 | 9,946,931 | 11,283,168 | 1,156,138 | |
09-11-2020 | PM | BXRX | Baudax Bio, Inc. | 21.31 | -0.72 | -0.84 | 0.00 | Baudax Bio EPS of $0.62 [11/9/2020 7:09 AM] |
1.08 | -0.11 (-9.24%) |
1.21 | 0.02 (1.68%) |
1.02 - 10.14 | 2,688,002 | 1,469,254 | 59,602 | ||
|